These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 8783577)
1. The role of atypical mole syndrome and cutaneous naevi in the development of melanoma. Easton D Cancer Surv; 1996; 26():237-49. PubMed ID: 8783577 [No Abstract] [Full Text] [Related]
2. [Risk factors for skin melanoma: genetic factors probably more important than exposure to sunlight]. Pavel S; Smit NP Ned Tijdschr Geneeskd; 2004 Nov; 148(46):2267-72. PubMed ID: 15584541 [TBL] [Abstract][Full Text] [Related]
3. The dysplastic nevus syndrome: precursors of hereditary and nonfamilial cutaneous melanoma. Greene MH Important Adv Oncol; 1986; ():173-91. PubMed ID: 3330532 [No Abstract] [Full Text] [Related]
4. The atypical-mole syndrome and predisposition to melanoma. Wachsmuth RC; Harland M; Bishop JA N Engl J Med; 1998 Jul; 339(5):348-9. PubMed ID: 9696648 [No Abstract] [Full Text] [Related]
5. [Connection between uveal melanoma and dysplastic naevus syndrome]. Hammer H; Tóth-Molnár E; Oláh J; Dobozy A Magy Onkol; 2005; 49(1):15-8. PubMed ID: 15902328 [TBL] [Abstract][Full Text] [Related]
7. [From gene to disease; from p16 to melanoma]. Gruis NA; Bergman W Ned Tijdschr Geneeskd; 2000 Oct; 144(44):2100-2. PubMed ID: 11103670 [TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Gandini S; Sera F; Cattaruzza MS; Pasquini P; Abeni D; Boyle P; Melchi CF Eur J Cancer; 2005 Jan; 41(1):28-44. PubMed ID: 15617989 [TBL] [Abstract][Full Text] [Related]
9. Risk of spots. Elder D Am J Dermatopathol; 1991 Dec; 13(6):630-1. PubMed ID: 1805658 [No Abstract] [Full Text] [Related]
10. Familial aggregation of malignant melanoma/dysplastic naevi and tumours of the nervous system: an original syndrome of tumour proneness. Bahuau M; Vidaud D; Kujas M; Palangié A; Assouline B; Chaignaud-Lebreton M; Prieur M; Vidaud M; Harpey JP; Lafourcade J; Caille B Ann Genet; 1997; 40(2):78-91. PubMed ID: 9259954 [TBL] [Abstract][Full Text] [Related]
11. [Can the risk of melanoma be calculated?]. Jung EG Z Hautkr; 1988 Jul; 63(7):559-62. PubMed ID: 3055724 [TBL] [Abstract][Full Text] [Related]
12. Gene-environment interaction in melanoma. Berwick M Forum (Genova); 2000; 10(3):191-200. PubMed ID: 11007929 [TBL] [Abstract][Full Text] [Related]
14. [Dysplastic nevi and the risk of melanoma: a guideline for patient care. Nederlandse Melanoom Werkgroep van de Vereniging voor Integrale Kankercentra]. Bergman W; van Voorst Vader PC; Ruiter DJ Ned Tijdschr Geneeskd; 1997 Oct; 141(42):2010-4. PubMed ID: 9550752 [TBL] [Abstract][Full Text] [Related]
15. Genetic relationship between nevus count or nevus density and cutaneous malignant melanoma. Claus EB; Giuffra L; Rogers J; Risch N Cytogenet Cell Genet; 1992; 59(2-3):188-90. PubMed ID: 1737496 [No Abstract] [Full Text] [Related]
16. Trajectories of premalignancy during the journey from melanocyte to melanoma. Colebatch AJ; Scolyer RA Pathology; 2018 Jan; 50(1):16-23. PubMed ID: 29132722 [TBL] [Abstract][Full Text] [Related]
17. [Genetic counseling and DNA testing in patients with increased risks for malignant melanoma]. Itin PH; Fistarol SK Ther Umsch; 2003 Aug; 60(8):469-72. PubMed ID: 14502854 [TBL] [Abstract][Full Text] [Related]
18. [Risk factors for the formation of malignant melanoma]. Weiss J; Jung EG Dtsch Krankenpflegez; 1989 Jul; 42(7):447-8. PubMed ID: 2518171 [No Abstract] [Full Text] [Related]